Zea mays (Blue Corn)

Blue corn (Zea mays) contains high concentrations of anthocyanins, particularly cyanidin-3-glucoside, which drive its antioxidant and cardiometabolic effects. These pigmented polyphenols inhibit ACE and DPP-IV enzymes, linking blue corn to blood pressure reduction and improved glucose regulation.

Origin & History

Zea mays (blue corn) is a cereal grain native to Mesoamerica, distinguished from regular corn by its anthocyanin content which creates its characteristic blue coloration. Commercial preparations include whole grain extracts, cob and husk extracts from processing byproducts, and isolated peptides derived from α-zein protein through enzymatic hydrolysis.

Historical & Cultural Context

Corn (Zea mays) has been a staple crop in Mesoamerican cultures for over 9,000 years, serving as a primary carbohydrate source and ceremonial food. However, specific documentation of traditional medicinal uses of blue corn varieties in indigenous medicine systems is not provided in available research.

Health Benefits

• Enhanced HDL cholesterol and reduced systolic blood pressure - one human study showed improvements, though sample size not specified
• ACE and DPP-IV enzyme inhibition - in vitro studies demonstrate potential for blood pressure and glucose regulation
• Antioxidant protection - purple corn extracts activated heme oxygenase-1 and modulated autophagy pathways in retinal cells (in vitro)
• Alpha-glucosidase inhibition - specific peptides (YP, PP) showed enzyme inhibition in laboratory studies
• Cell cycle arrest in cancer cells - anthocyanins demonstrated this effect in cell culture studies only

How It Works

Cyanidin-3-glucoside and other anthocyanins in blue corn inhibit angiotensin-converting enzyme (ACE), reducing the conversion of angiotensin I to angiotensin II and thereby lowering vascular resistance and systolic blood pressure. Simultaneously, DPP-IV inhibition by these polyphenols slows the degradation of GLP-1 and GIP incretins, prolonging insulin secretion and improving postprandial glucose control. The anthocyanins also scavenge reactive oxygen species and upregulate endogenous antioxidant enzymes, providing cellular protection against oxidative stress.

Scientific Research

Clinical evidence is extremely limited with only one human study showing blue maize extract enhanced HDL cholesterol and decreased blood pressure, though study details and PMIDs are not provided. Most research remains preclinical, including in vitro studies on ACE/DPP-IV inhibition and cell culture models showing 80% cell viability at 20 µg/mL of purple corn extract.

Clinical Summary

One human study demonstrated that blue corn consumption improved HDL cholesterol levels and reduced systolic blood pressure, though the sample size was not specified in available literature, limiting statistical confidence. In vitro studies have confirmed meaningful ACE and DPP-IV enzyme inhibitory activity in blue corn extracts, providing mechanistic plausibility for these cardiometabolic effects. The majority of antioxidant data derives from purple and blue corn extract studies conducted in cell culture models, which cannot be directly extrapolated to clinical outcomes. Overall, evidence is preliminary and promising, but large-scale randomized controlled trials are needed to establish dosing and efficacy in human populations.

Nutritional Profile

Blue corn (Zea mays) provides approximately 350-365 kcal per 100g dry weight. Macronutrients: carbohydrates 70-75g/100g (predominantly starch, with resistant starch content ~4-6g/100g, higher than yellow corn), protein 8-10g/100g (higher lysine content than yellow corn, though still limiting; notable zein prolamin fractions), fat 3.5-4.5g/100g (predominantly unsaturated: linoleic acid ~50-55% of fatty acids, oleic acid ~25-30%), dietary fiber 7-9g/100g (insoluble:soluble ratio approximately 3:1). Key micronutrients: magnesium 90-110mg/100g, phosphorus 270-300mg/100g, potassium 280-320mg/100g, iron 2.5-3.5mg/100g (bioavailability limited by phytic acid content ~800-1000mg/100g; nixtamalization reduces phytate ~50% and improves mineral bioavailability), zinc 2-3mg/100g, manganese 0.4-0.6mg/100g. B vitamins: niacin ~3.5mg/100g (largely bound as niacytin, bioavailable only after alkaline processing/nixtamalization), thiamine 0.3-0.4mg/100g, B6 0.3-0.5mg/100g. Distinguishing bioactive compounds: anthocyanins 150-1600mg/100g dry weight depending on cultivar and growing conditions (cyanidin-3-glucoside predominant at ~60-70% of total anthocyanins, with pelargonidin-3-glucoside, peonidin-3-glucoside, and acylated derivatives; whole grain blue corn masa averages ~300-500mg/100g); total polyphenols 800-2000mg GAE/100g; protocatechuic acid and other phenolic acids present. Carotenoids: lutein and zeaxanthin ~0.5-1.5mg/100g (lower than yellow corn). Glycemic index approximately 35-45 (lower than refined yellow corn products, attributed to higher resistant starch and anthocyanin content inhibiting alpha-glucosidase). Bioavailability note: anthocyanin absorption is pH-sensitive and relatively low (~5-10% systemic absorption); nixtamalization preserves ~60-80% of anthocyanins when lime concentration and heating are controlled.

Preparation & Dosage

No standardized human dosages have been established through clinical trials. In cell culture studies, purple corn cob and husk extract (PCHE) was tested at 5-50 µg/mL, with 15-20 µg/mL showing biological activity. The single human study with cardiovascular benefits did not specify dosage in available abstracts. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Anthocyanin-rich berries, Alpha-lipoic acid, Chromium, Cinnamon extract, Green tea extract

Safety & Interactions

Blue corn consumed as a whole food is generally recognized as safe, with no significant adverse effects reported at typical dietary intake levels. Individuals taking antihypertensive medications such as ACE inhibitors (e.g., lisinopril, enalapril) should exercise caution, as blue corn anthocyanins may produce additive blood pressure-lowering effects. Similarly, those on DPP-IV inhibitor medications (e.g., sitagliptin, saxagliptin) for type 2 diabetes should consult a healthcare provider before supplementing with concentrated blue corn extracts to avoid compounded hypoglycemic risk. Safety data during pregnancy and lactation is insufficient, and concentrated anthocyanin supplements derived from blue corn are not recommended for these populations without medical guidance.